Home LiteratureArticle Details
PMID: 3159749 Published · ppublish English Journal Article

Ciprofloxacin disk susceptibility tests: interpretive zone size standards for 5-microgram disks.

Journal of clinical microbiology ·Vol. 21 ·No. 6 ·1985-06-00 ·Pages 880-3

Barry AL, Fass RJ, Anhalt JP, Neu HC, Thornsberry C, Tilton RC, Painter BG, Washington JA

Abstract

Evaluations of 5-microgram ciprofloxacin disk diffusion susceptibility tests were performed independently by seven different investigators. The results of the separate tests were combined to increase the number of resistant strains in the challenge set of microorganisms. Based on data with 2,652 isolates, the following interpretive breakpoints are tentatively proposed for use in ongoing clinical trials of ciprofloxacin: less than or equal to 15 mm, resistant (MIC greater than 2.0 micrograms/ml); 16 to 20 mm, intermediate (1.0 less than MIC less than or equal to 2.0 micrograms/ml); and greater than or equal to 21 mm, susceptible (MIC less than or equal to 1.0 micrograms/ml). Disk tests with Streptococcus spp. and with Pseudomonas maltophilia were not reliable; other microorganisms were accurately categorized by the disk diffusion test.

MeSH Terms
Acinetobacter/drug effects Ciprofloxacin Enterobacteriaceae/drug effects Escherichia coli/drug effects Microbial Sensitivity Tests/standards Pseudomonas/drug effects Quinolines/pharmacology Staphylococcus aureus/drug effects Streptococcus/drug effects
Chemicals
Quinolines Ciprofloxacin
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Barry A L
Fass R J
Anhalt J P
Neu H C
Thornsberry C
Tilton R C
Painter B G
Washington J A
References (18)
18 references, click to expand
  1. Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.
    Antimicrob Agents Chemother. 1984 May;25(5):633-7 PMID: 6233935
  2. In-vitro studies with ciprofloxacin, a new 4-quinolone compound.
    J Antimicrob Chemother. 1984 Apr;13(4):333-46 PMID: 6233250
  3. Pharmacokinetics of intravenously administered ciprofloxacin.
    Antimicrob Agents Chemother. 1984 Aug;26(2):208-10 PMID: 6486762
  4. Diffusion of ciprofloxacin into prostatic fluid.
    Eur J Clin Microbiol. 1984 Aug;3(4):360-2 PMID: 6489327
  5. Dose- and sex-independent disposition of ciprofloxacin.
    Eur J Clin Microbiol. 1984 Aug;3(4):363-6 PMID: 6489328
  6. Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers.
    Antimicrob Agents Chemother. 1984 Nov;26(5):741-4 PMID: 6517556
  7. Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers.
    Antimicrob Agents Chemother. 1984 Nov;26(5):757-61 PMID: 6517559
  8. Antibiotic susceptibility testing by a standardized single disk method.
    Am J Clin Pathol. 1966 Apr;45(4):493-6 PMID: 5325707
  9. Susceptibility tests of anaerobic bacteria: statistical and clinical considerations.
    J Infect Dis. 1974 Dec;130(6):588-94 PMID: 4372272
  10. In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.
    Antimicrob Agents Chemother. 1983 Apr;23(4):559-64 PMID: 6222695
  11. In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid.
    Eur J Clin Microbiol. 1983 Apr;2(2):111-5 PMID: 6222896
  12. Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.
    Antimicrob Agents Chemother. 1983 Aug;24(2):302-4 PMID: 6227281
  13. In vitro activity of ciprofloxacin (Bay o 9867).
    Antimicrob Agents Chemother. 1983 Oct;24(4):568-74 PMID: 6228192
  14. Pharmacokinetics and tissue penetration of ciprofloxacin.
    Antimicrob Agents Chemother. 1983 Nov;24(5):784-6 PMID: 6660852
  15. In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.
    Antimicrob Agents Chemother. 1984 Mar;25(3):331-5 PMID: 6721464
  16. Effect of inoculum, pH, and medium on the activity of ciprofloxacin against anaerobic bacteria.
    Antimicrob Agents Chemother. 1984 Mar;25(3):342-3 PMID: 6721466
  17. The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid.
    J Antimicrob Chemother. 1984 Apr;13(4):325-31 PMID: 6233249
  18. Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations.
    Antimicrob Agents Chemother. 1984 Jun;25(6):775-7 PMID: 6234858
Article Info
Journal
Journal of clinical microbiology
Abbr.
J Clin Microbiol
ISSN
0095-1137
Published
1985-06-00
Pages
880-3
Language
English
Region
United States
NLM ID
7505564
PMCID
PMC271810
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]